Quick Summary
Covering the latest research from top Wall Street investment banks

DOE loan commitment benefits the U.S. nuclear supply chain; Goldman Sachs reiterates Buy on Cameco

Institution
Goldman Sachs
Date
2026-06-23
Authors
Brian Lee, CFA, Tyler Bisset, CFA, Keshav Choudhary
Company
Cameco Corp.
Ticker
CCJ.N
Industry
Uranium
Rating
Buy
BullishLow confidenceThe report believes the DOE's $17.5 billion conditional loan commitment is likely to accelerate procurement of long-cycle components for U.S. nuclear power, shorten deployment timelines for large reactors, and bring forward potential revenue and EBITDA recognition for Westinghouse and Cameco.
AuthorsBrian Lee, CFA, Tyler Bisset, CFA, Keshav Choudhary
Target price$133 / C$182
CoverageUnited States
Asset classesEquity
Business segmentsUranium、Fuel services、Westinghouse
Research firm divisions/subsidiariesGoldman Sachs(Other)

AI summary card

DOE loan commitment benefits the U.S. nuclear supply chain; Goldman Sachs reiterates Buy on Cameco

Goldman Sachs believes the DOE's $17.5 billion conditional loan commitment will support procurement of long-lead components for 10 large nuclear reactors, benefiting Westinghouse and Cameco, though actual project execution still depends on the satisfaction of loan conditions.

Reiterate Buy; 12-month target price is $133/C$182; disclosed price is $108.89/C$154.68.
Cameco Corp.CCJ.NBuy ratingDOE loan commitmentWestinghouseAP1000U.S. nuclear supply chain
  • The DOE's EDF office issued a $17.5 billion conditional loan commitment to support five eligible project sites, with each site advancing two large reactors.
  • The financing arrangement is expected to accelerate deployment of 10 large commercial nuclear reactors by up to three years, while reducing long-cycle component costs and improving supply chain efficiency.
  • Goldman Sachs estimates that each U.S. AP1000 reactor could contribute approximately $225 million in adjusted EBITDA to Cameco over a 12-year period.
  • The report keeps current earnings forecasts unchanged, pending loan approval and fulfillment of conditions for specific projects before revising estimates.

Report interpretation

Overview

This report focuses on the potential incremental opportunity for Cameco Corp. and its Westinghouse business driven by the U.S. DOE's conditional loan commitment. The DOE plans to provide $17.5 billion in loans to procure in advance the long-lead components required for large nuclear reactors, supporting five project sites and a total of 10 large reactors. Goldman Sachs believes this arrangement will help reduce costs, improve supply chain efficiency, and potentially bring forward new reactor deployment by up to three years.

Core views

The core view is that the DOE loan commitment is an important catalyst for the U.S. nuclear supply chain, with Westinghouse's AP1000—described as the only large advanced nuclear reactor technology licensed and operating in the United States—in a direct beneficiary position. If projects advance, Westinghouse and Cameco may achieve earlier revenue and EBITDA recognition. However, because the loans still need to satisfy technical, environmental, legal, and financial conditions, and specific projects have not yet been finally determined, the report does not adjust earnings forecasts at this stage.

Analysis framework

The report uses an event-driven analysis, project economics modeling, and a sum-of-the-parts valuation framework: it first assesses the impact of DOE loans on procurement of nuclear long-lead components and construction timelines, then estimates the potential adjusted EBITDA contribution of each AP1000 reactor to Westinghouse and Cameco, and finally derives the target price using EV/EBITDA multiples for the three major segments of Uranium, Fuel services, and Westinghouse.

Methodology notes

  • Valuation methodsSum-of-the-parts valuation

    EV/EBITDA multiple method

    The 12-month target price of $133/C$182 is based on a sum-of-the-parts valuation: Uranium uses 25x EV/EBITDA, Fuel services uses 30x EV/EBITDA, and Westinghouse uses 40x EV/EBITDA, all based on Q5-Q8 EBITDA estimates.

  • Project economicsAP1000 revenue and EBITDA contribution estimate

    Single-reactor EBITDA uplift

    Goldman Sachs estimates that each U.S. AP1000 reactor can contribute approximately $225 million in adjusted EBITDA over a 12-year period, assuming Westinghouse takes on about 33% of the project scope within a total $8 billion capital expenditure and achieves a 17.5% adjusted EBITDA margin.

  • Factor frameworkGS Factor Profile

    Growth, financial returns, valuation multiples, and composite factors

    The appendix explains that Goldman Sachs assesses a stock's attributes relative to the market and industry peers through growth, financial returns, valuation multiples, and composite indicators.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Cameco Corp. (CCJ.N)
    Covered name; Goldman Sachs reiterates Buy
    Strengths
    It has exposure to Uranium, Fuel services, and Westinghouse, and can benefit from an accelerated nuclear construction cycle and expansion of the U.S. nuclear supply chain.
    Weaknesses
    Current earnings forecasts have not been raised because of the loan commitment, indicating uncertainty remains around project conversion and timing.
    Comparison
    The rating is relative to Goldman Sachs' covered stock universe; the target price uses a sum-of-the-parts valuation rather than a single-business multiple.
    Risks
    Falling commodity prices, mining accidents affecting output, changes in sales and delivery timing, and competition or delays in Westinghouse-related reactor construction.
  • Westinghouse
    Key beneficiary business in Cameco's valuation
    Strengths
    The AP1000 is described in the report as the only large advanced nuclear reactor technology licensed and operating in the United States, and it may procure long-lead components at fixed prices.
    Weaknesses
    Projects require joint equity investment by Westinghouse and utility or energy company partners, and must satisfy DOE loan conditions.
    Comparison
    In the segment valuation, Westinghouse uses a 40x EV/EBITDA multiple, higher than the multiples for the Uranium and Fuel services segments.
    Risks
    Risks related to partner selection, equity commitments, regulatory conditions, supply chain execution, and construction delays.
  • AP1000 large nuclear reactor
    Core technology and project vehicle supported by the DOE loan
    Strengths
    Each reactor is estimated to bring approximately $225 million in adjusted EBITDA to Cameco and drive concentrated revenue recognition in the middle phase of construction.
    Weaknesses
    Long-lead components typically require years to establish, and procurement has traditionally only been coordinated after a final investment decision.
    Comparison
    The report emphasizes the AP1000's licensed and operating status among large advanced nuclear reactors in the United States.
    Risks
    There is uncertainty around final investment decisions, satisfaction of loan conditions, construction timelines, and the realization of lower costs.

Key data

  • DOE conditional loan commitment$17.5bnUsed to support procurement of long-lead components for the U.S. nuclear supply chain.
  • Supported project scale5 eligible project sites, 10 large reactorsEach project site corresponds to two large reactors.
  • Potential deployment accelerationup to 3 years earlierThe financing arrangement is intended to enable earlier procurement of long-lead components, thereby shortening construction timelines.
  • Project upfront equity commitment$500mn + $500mn, $1.0bn total per projectWestinghouse and the project partner must each commit $500 million of equity upfront before DOE loan funds can be accessed.
  • AP1000 annual launch capacity4 units per yearThe report states that Westinghouse has the capability to start four new AP1000 units per year.
  • Potential contribution per AP1000approximately $225mn adjusted EBITDACovers a 12-year period, including 10 years of construction and 2 years of commissioning.
  • Revenue recognition cadenceapproximately 50% in years 4-6, approximately 75% in years 3-7Heavy equipment procurement is expected to occur in year 3.
  • Target price$133 / C$182Based on a sum-of-the-parts valuation of Uranium, Fuel services, and Westinghouse.

Impact & implications

If the DOE loan is ultimately implemented and helps secure project equity, Cameco's Westinghouse business may recognize revenue and EBITDA related to new nuclear construction earlier, and the market may also re-rate the value of its nuclear supply chain assets. The near-term impact is more catalyst-like, with the key validation point being whether the loan converts into specific projects, purchase orders, and construction timelines.

Risks

  • Commodity prices are lower than expected.
  • Accidents at Cameco's operating mines affect production.
  • Changes in sales and delivery timing affect earnings recognition.
  • Westinghouse-related reactor construction faces competition or delays.
  • The DOE loan remains a conditional commitment and must satisfy technical, environmental, legal, and financial conditions.
  • Delays in project partner equity commitments or final investment decisions may weaken the pull-forward effect on revenue and EBITDA.

What to watch

  • Whether the DOE loan moves from a conditional commitment to actual funding for specific projects.
  • The final selection of the five eligible project sites and potential partners.
  • Whether Westinghouse and project partners complete the combined $1 billion equity commitment per project.
  • AP1000 long-lead component purchase orders, fixed-price arrangements, and supply chain delivery progress.
  • Whether Cameco raises its Westinghouse revenue, EBITDA, or target price assumptions in subsequent reports.
  • Final investment decisions and construction schedules for large U.S. nuclear reactors.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins